hCD20(2)
Nomenclature
C57BL/6JSmo-Ms4a1tm3(hCD20)Smoc
Cat. NO.
NM-HU-200114
Strain State
Repository Live
Gene Summary
Gene Symbol
Ms4a1
Model Description
Validation Data

Fig1. Detection of hCD20 expression on mCD19+ B cells in blood in hCD20 knockin mice.

Fig 2.Frequency of leukocyte subpopulations in the blood by flow cytometry
Blood was collected from WT C57BL/6 mice(11-week-old, female, n=3) and HO hCD20(2) mice (10-week-old, female, n=5). Flow cytometry analysis of frequencies of lymphocyte subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 3.Frequency of leukocyte subpopulations in the blood by flow cytometry
Blood was collected from WT C57BL/6 mice(11-week-old, male, n=3) and HO hCD20(2) mice (10-week-old, male, n=5). Flow cytometry analysis of frequencies of (A) lymphocyte and (B) myeloid subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 4.Frequency of leukocyte and myeloid subpopulations in the spleen by flow cytometry
Spleen was collected from WT C57BL/6 mice(11-week-old, female, n=3) and HO hCD20(2) mice (10-week-old, female, n=5). Flow cytometry analysis of frequencies of (A) lymphocyte and (B) myeloid subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 5.Frequency of leukocyte and myeloid subpopulations in the spleen by flow cytometry
Spleen was collected from WT C57BL/6 mice(11-week-old, male, n=3) and HO hCD20(2) mice (10-week-old, male, n=5). Flow cytometry analysis of frequencies of (A) lymphocyte and (B) myeloid subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig6. Rituximab can bind to lymphocytes of hCD20 knockin mice.

Fig.7 In vivo B cells depletion in hCD20 knockin mice. (In cooperation with a third party)
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more